Untargeted metabolomic profiling reveals mTORC1-dependent regulation of amino acid utilization in lymphatic endothelial cells

This study demonstrates that mTORC1 signaling, via its component RAPTOR, is essential for coordinating amino acid utilization in lymphatic endothelial cells by regulating glutaminolysis and branched-chain amino acid catabolism, thereby supporting lymphatic vessel formation.

The Gist

The Big Picture: The Body's Drainage System

Imagine your body is a massive, bustling city. The lymphatic system is the city's drainage and delivery network. It sucks up extra water (fluid) from the streets, transports heavy packages (fats and immune cells), and keeps everything from flooding.

The workers who build and maintain this network are called Lymphatic Endothelial Cells (LECs). Just like construction workers need tools and fuel to build roads, these cells need energy and raw materials to grow new vessels.

The Foreman: mTORC1

Inside every cell, there is a "foreman" or a master switch called mTORC1. Think of mTORC1 as the Project Manager of the cell. Its job is to decide:

1. Do we have enough fuel?
2. Should we start building (growing)?
3. Which raw materials (amino acids) should we use?

Previously, scientists knew this Project Manager told the cells to burn sugar (glycolysis) and process a specific fuel called glutamine to build lymphatic vessels. But they didn't know exactly how the manager handled the rest of the supply chain.

The Experiment: Firing the Foreman

In this study, the researchers decided to see what happens if they remove the Project Manager (mTORC1) from the construction crew. They did this by turning off a key part of the manager called RAPTOR.

They used a high-tech scanner (metabolomics) to look at the "trash cans" and "supply shelves" inside the cells to see what changed when the manager was gone.

What They Found: A Supply Chain Chaos

When the Project Manager was removed, the cell didn't just slow down; it got confused about its food supply. Here is what happened, broken down by analogy:

1. The Glutamine Traffic Jam

• Normal Life: The cell takes in Glutamine (a raw material), breaks it down into Glutamic Acid, and uses it to power the engine.
• Without the Manager: The factory stopped breaking down Glutamine. It piled up in the warehouse (high levels of Glutamine), but the finished products (Glutamic Acid and Aspartic Acid) ran out.
• The Surprise: The researchers also found two rare items, N-acetyl-glutamic acid and N-acetyl-aspartic acid, which usually live in the liver or brain. They were present in these cells, but when the manager was fired, these rare items disappeared too. It's like finding a rare spice in a bakery, and then realizing the bakery can't make it anymore without the head chef.

2. The "Emergency Ration" Response (Asparagine)

• The Problem: Because the Glutamine breakdown stopped, the cell couldn't make enough Asparagine (another amino acid) on its own.
• The Fix: The cell panicked and started shouting, "We need Asparagine from the outside!" It turned up the volume on its delivery trucks (transporters) to suck in as much Asparagine as possible from the environment.
• The Result: Even though the cell couldn't make it internally, it had too much Asparagine floating around because it was hoarding it from the outside world.

3. The Protein Building Blocks (BCAAs and Others)

• The Problem: The cell has a special set of building blocks called BCAAs (Branched-Chain Amino Acids) and others like Threonine and Lysine. Usually, the cell breaks these down for energy or uses them to build proteins.
• Without the Manager: The cell stopped breaking them down (the recycling plant closed), and it also stopped building proteins (the construction site halted).
• The Result: The warehouse got flooded with unused building blocks. The cell was sitting on a mountain of unused bricks because the foreman who told the workers "Start building!" was gone.

The Conclusion: Why This Matters

The study reveals that mTORC1 is the ultimate traffic controller for amino acids.

• When mTORC1 is working: It directs the flow of materials, breaks down fuel efficiently, and tells the cell to build new vessels.
• When mTORC1 is broken: The cell gets stuck. It hoards some materials, runs out of others, and stops building.

Why should you care?
If the lymphatic system can't build new vessels because the cells are confused about their food supply, the body's drainage system fails. This can lead to swelling (lymphedema), poor fat absorption, or trouble fighting infections. Understanding this "traffic control" helps scientists figure out how to fix broken drainage systems in the future.

Summary in One Sentence

The researchers discovered that the cell's "Project Manager" (mTORC1) is essential not just for burning fuel, but for organizing the entire supply chain of amino acids; without it, the cell's warehouse gets clogged with unused materials, and the construction of the body's drainage system grinds to a halt.

Technical Summary

1. Problem Statement

The lymphatic vascular system is critical for fluid homeostasis, fat absorption, and immune trafficking. Its development (lymphangiogenesis) relies heavily on cellular metabolism. Previous research established that the mechanistic target of rapamycin complex 1 (mTORC1), specifically via its essential component RAPTOR, promotes lymphatic vessel formation by regulating glycolysis and glutaminolysis. However, the global impact of mTORC1 signaling on the broader metabolic landscape of lymphatic endothelial cells (LECs), particularly regarding amino acid utilization and catabolism, remained incompletely understood. This study aims to fill that gap by defining how mTORC1 inhibition alters the metabolome of LECs.

2. Methodology

The study employed an integrated multi-omics approach combining untargeted metabolomics and transcriptomics:

• Cell Model: Human dermal lymphatic endothelial cells (HDLECs) were used.
• Genetic Manipulation: RAPTOR was depleted using siRNA knockdown to inhibit mTORC1 signaling, with non-targeting siRNA serving as the control.
• Untargeted Metabolomics:
  • Extraction: Metabolites were extracted using cold methanol/water.
  • Analysis: Liquid Chromatography-Mass Spectrometry (LC-MS) was performed using a Thermo Vanquish UPLC-Exploris 240 Orbitrap MS.
  • Conditions: Hydrophilic Interaction Chromatography (HILIC) mode was used for separation. Data was collected in both positive and negative ionization modes (70–1050 m/z).
  • Processing: Peaks were identified using in-house standards and databases (HMDB, Lipidmap, METLIN, etc.). Only metabolites with a coefficient of variation (CV) < 20% in quality controls and present in >80% of samples were analyzed.
• Transcriptomics: Re-analysis of a previously published RNA-seq dataset (GSE242082) was conducted to correlate metabolite changes with gene expression (specifically amino acid transporters and catabolic enzymes).
• Validation: Western blotting was used to confirm RAPTOR knockdown efficiency and assess the phosphorylation status of mTORC1 downstream effectors (4E-BP1, S6K1, S6RP).
• Statistical Analysis: Principal Component Analysis (PCA) was used for clustering. Differential metabolites were identified using Welch's t-test with Benjamini-Hochberg false discovery rate (FDR) correction (adjusted p < 0.05).

3. Key Contributions

• Global Metabolic Profiling: Provided the first untargeted metabolomic map of RAPTOR-deficient LECs, revealing that mTORC1 inhibition causes a systemic shift in amino acid homeostasis, not just in energy pathways.
• Discovery of Novel Metabolites: Unexpectedly detected and quantified N-acetyl-glutamic acid and N-acetyl-aspartic acid in LECs, metabolites typically associated with the liver and brain, respectively.
• Mechanistic Link to Transport: Demonstrated that mTORC1 inhibition triggers a compensatory upregulation of specific amino acid transporters (SLC38A2 for asparagine, SLC7A2 for arginine) to counteract metabolic stress.
• BCAA Catabolism Defect: Identified a specific block in branched-chain amino acid (BCAA) catabolism due to the downregulation of the enzyme BCAT2, linking this defect to impaired lymphangiogenesis.

4. Key Results

A. Global Metabolic Shift

PCA analysis showed clear separation between control and RAPTOR-deficient HDLECs. Of the 192 significantly altered metabolites, ~20% were related to amino acid metabolism. TCA cycle metabolites (e.g., isocitric acid) were confirmed to be reduced, validating previous findings.

B. Impaired Glutaminolysis and N-Acetylated Metabolites

• Glutamine Accumulation: RAPTOR depletion led to a buildup of glutamine and a reduction in glutamic acid and aspartic acid. This confirms a blockade at the conversion step catalyzed by glutaminase (GLS).
• N-Acetyl Metabolites: Levels of N-acetyl-glutamic acid and N-acetyl-aspartic acid were significantly decreased. This suggests mTORC1 regulates the acetylation pathways of these amino acids in LECs, a finding previously unreported in this cell type.

C. Compensatory Asparagine Uptake

• Despite impaired endogenous synthesis (due to low aspartate), intracellular asparagine levels increased in RAPTOR-deficient cells.
• Mechanism: Transcriptomic analysis revealed an ~80% upregulation of SLC38A2 (an asparagine transporter). This suggests LECs compensate for glutaminolysis failure by scavenging extracellular asparagine.

D. Arginine Catabolism and Transport

• RAPTOR depletion caused significant accumulation of arginine, ornithine, and putrescine.
• Mechanism: The expression of the arginine transporter SLC7A2 (CAT-2) was upregulated >2-fold, indicating enhanced arginine uptake.

E. BCAA Catabolism and Translational Control

• BCAA Accumulation: Intracellular levels of valine and isoleucine increased by ~50%.
• Mechanism: The catabolic enzyme BCAT2 was significantly downregulated at the mRNA level.
• Translation Defect: Levels of threonine, histidine, and lysine also accumulated. Since catabolism of these amino acids is minimal in LECs, this accumulation points to reduced protein synthesis.
• Validation: Western blots confirmed reduced phosphorylation of 4E-BP1, S6K1, and S6RP, confirming that mTORC1 inhibition suppresses translational activity, leading to the "backup" of essential amino acids.

5. Significance

• Metabolic Coordination: The study establishes mTORC1 as a central coordinator of amino acid utilization in LECs, regulating not only catabolism (glutaminolysis, BCAA breakdown) but also uptake (transporters) and anabolic processes (protein synthesis).
• Lymphangiogenesis Mechanism: The findings suggest that defective lymphatic vessel formation in RAPTOR-deficient cells is driven by a "metabolic crisis" involving:
  1. Blocked energy production (impaired glutaminolysis/TCA).
  2. Disrupted signaling (accumulated BCAAs may inhibit VEGFR3 signaling, as seen in heart failure models).
  3. Reduced biosynthetic capacity (suppressed translation).
• Therapeutic Implications: Understanding how mTORC1 regulates specific amino acid transporters (like SLC38A2 and SLC7A2) and catabolic enzymes (BCAT2) offers new potential targets for treating lymphatic disorders, lymphedema, or conditions where lymphangiogenesis is dysregulated (e.g., cancer metastasis, heart failure).

In conclusion, this work moves beyond the known role of mTORC1 in glycolysis to reveal a complex, multi-layered regulatory network governing amino acid metabolism that is essential for the structural and functional integrity of the lymphatic vasculature.